The need for early intervention for psychosis to persist throughout the COVID-19 pandemic and beyond

por O’Donoghue, B., O’Connor, K., Thompson, A., McGorry, P.
Publicado 2020

“Attenuated psychotic symptoms syndrome” as a risk syndrome of psychosis, diagnosis in DSM-V: The debate

por Shrivastava, Amresh, McGorry, P. D., Tsuang, Ming, Woods, Scott W., Cornblatt, Barbara A., Corcoran, Cheryl, Carpenter, William
Publicado 2011

Erythrocyte glutathione levels as long-term predictor of transition to psychosis

por Lavoie, S, Berger, M, Schlögelhofer, M, Schäfer, M R, Rice, S, Kim, S-W, Hesse, J, McGorry, P D, Smesny, S, Amminger, G P
Publicado 2017

Correlates of substance use in a large naturalistic cohort of young people with early and emerging psychosis

por El-Hage, D., Gao, C. X., Bedi, G., Guerin, A., Francey, S., Stavely, H., Rickwood, D., Telford, N., McGorry, P., Thompson, A., Brown, Ellie
Publicado 2023

Predictors of treatment response in young people at ultra-high risk for psychosis who received long-chain omega-3 fatty acids

por Amminger, G P, Mechelli, A, Rice, S, Kim, S-W, Klier, C M, McNamara, R K, Berk, M, McGorry, P D, Schäfer, M R
Publicado 2015

Divergent effects of first-generation and second-generation antipsychotics on cortical thickness in first-episode psychosis

por Ansell, B. R. E., Dwyer, D. B., Wood, S. J., Bora, E., Brewer, W. J., Proffitt, T. M., Velakoulis, D., McGorry, P. D., Pantelis, C.
Publicado 2015

Randomized Controlled Trial of Clozapine and CBT for First-Episode Psychosis with Enduring Positive Symptoms: A Pilot Study

por Edwards, J., Cocks, J., Burnett, P., Maud, D., Wong, L., Yuen, H. P., Harrigan, S. M., Herrman-Doig, T., Murphy, B., Wade, D., McGorry, P. D.
Publicado 2011

Omega-6 to omega-3 polyunsaturated fatty acid ratio and subsequent mood disorders in young people with at-risk mental states: a 7-year longitudinal study

por Berger, M E, Smesny, S, Kim, S-W, Davey, C G, Rice, S, Sarnyai, Z, Schlögelhofer, M, Schäfer, M R, Berk, M, McGorry, P D, Amminger, G P
Publicado 2017

Prediction of transition from ultra-high risk to first-episode psychosis using a probabilistic model combining history, clinical assessment and fatty-acid biomarkers

por Clark, S R, Baune, B T, Schubert, K O, Lavoie, S, Smesny, S, Rice, S M, Schäfer, M R, Benninger, F, Feucht, M, Klier, C M, McGorry, P D, Amminger, G P
Publicado 2016

Neuroprotection after a first episode of mania: a randomized controlled maintenance trial comparing the effects of lithium and quetiapine on grey and white matter volume

por Berk, M, Dandash, O, Daglas, R, Cotton, S M, Allott, K, Fornito, A, Suo, C, Klauser, P, Liberg, B, Henry, L, Macneil, C, Hasty, M, McGorry, P, Pantelis, Cs, Yücel, M
Publicado 2017

Neuroprotection after a first episode of mania: a randomized controlled maintenance trial comparing the effects of lithium and quetiapine on grey and white matter volume

por Berk, M, Dandash, O, Daglas, R, Cotton, S M, Allott, K, Fornito, A, Suo, C, Klauser, P, Liberg, B, Henry, L, Macneil, C, Hasty, M, McGorry, P, Pantelis, Cs, Yücel, M
Publicado 2017

Effects of NRG1 and DAOA genetic variation on transition to psychosis in individuals at ultra-high risk for psychosis

por Bousman, C A, Yung, A R, Pantelis, C, Ellis, J A, Chavez, R A, Nelson, B, Lin, A, Wood, S J, Amminger, G P, Velakoulis, D, McGorry, P D, Everall, I P, Foley, D L
Publicado 2013

ENACT: a protocol for a randomised placebo-controlled trial investigating the efficacy and mechanisms of action of adjunctive N-acetylcysteine for first-episode psychosis

por Cotton, S. M., Berk, M., Watson, A., Wood, S., Allott, K., Bartholomeusz, C. F., Bortolasci, C. C., Walder, K., O’Donoghue, B., Dean, O. M., Chanen, A., Amminger, G. P., McGorry, P. D., Burnside, A., Uren, J., Ratheesh, A., Dodd, S.
Publicado 2019

Psychosis prevalence and physical, metabolic and cognitive co-morbidity: data from the second Australian national survey of psychosis

por Morgan, V. A., McGrath, J. J., Jablensky, A., Badcock, J. C., Waterreus, A., Bush, R., Carr, V., Castle, D., Cohen, M., Galletly, C., Harvey, C., Hocking, B., McGorry, P., Neil, A. L., Saw, S., Shah, S., Stain, H. J., Mackinnon, A.
Publicado 2014

Reduced parahippocampal cortical thickness in subjects at ultra-high risk for psychosis

por Tognin, S., Riecher-Rössler, A., Meisenzahl, E. M., Wood, S. J., Hutton, C., Borgwardt, S. J., Koutsouleris, N., Yung, A. R., Allen, P., Phillips, L. J., McGorry, P. D., Valli, I., Velakoulis, D., Nelson, B., Woolley, J., Pantelis, C., McGuire, P., Mechelli, A.
Publicado 2014

PET imaging of putative microglial activation in individuals at ultra-high risk for psychosis, recently diagnosed and chronically ill with schizophrenia

por Di Biase, M A, Zalesky, A, O'keefe, G, Laskaris, L, Baune, B T, Weickert, C S, Olver, J, McGorry, P D, Amminger, G P, Nelson, B, Scott, A M, Hickie, I, Banati, R, Turkheimer, F, Yaqub, M, Everall, I P, Pantelis, C, Cropley, V
Publicado 2017

NEURAPRO: a multi-centre RCT of omega-3 polyunsaturated fatty acids versus placebo in young people at ultra-high risk of psychotic disorders—medium-term follow-up and clinical cour...

por Nelson, B., Amminger, G. P., Yuen, H. P., Markulev, C., Lavoie, S., Schäfer, M. R., Hartmann, J. A., Mossaheb, N., Schlögelhofer, M., Smesny, S., Hickie, I. B., Berger, G., Chen, E. Y. H., de Haan, L., Nieman, D. H., Nordentoft, M., Riecher-Rössler, A., Verma, S., Thompson, A., Yung, A. R., McGorry, P. D.
Publicado 2018